» Articles » PMID: 18086852

AdeIJK, a Resistance-nodulation-cell Division Pump Effluxing Multiple Antibiotics in Acinetobacter Baumannii

Overview
Specialty Pharmacology
Date 2007 Dec 19
PMID 18086852
Citations 185
Authors
Affiliations
Soon will be listed here.
Abstract

We have identified a second resistance-nodulation-cell division (RND)-type efflux pump, AdeIJK, in clinical isolate Acinetobacter baumannii BM4454. The adeI, adeJ, and adeK genes encode, respectively, the membrane fusion, RND, and outer membrane components of the pump. AdeJ belongs to the AcrB protein family (57% identity with AcrB from Escherichia coli). mRNA analysis by Northern blotting and reverse transcription-PCR indicated that the genes were cotranscribed. Overexpression of the cloned adeIJK operon was toxic in both E. coli and Acinetobacter. The adeIJK genes were detected in all of the 60 strains of A. baumannii tested. The two latter observations suggest that the AdeIJK complex might contribute to intrinsic but not to acquired antibiotic resistance in Acinetobacter. To characterize the substrate specificity of the pump, we have constructed derivatives of BM4454 in which adeIJK (strain BM4579), adeABC (strain BM4561), or both groups of genes (strain BM4652) were inactivated by deletion-insertion. Determination of the antibiotic susceptibility of these strains and of BM4652 and BM4579, in which the adeIJK operon was provided in trans, indicated that the AdeIJK pump contributes to resistance to beta-lactams, chloramphenicol, tetracycline, erythromycin, lincosamides, fluoroquinolones, fusidic acid, novobiocin, rifampin, trimethoprim, acridine, safranin, pyronine, and sodium dodecyl sulfate. The chemical structure of these molecules suggests that amphiphilic compounds are the preferred substrates. The AdeABC and AdeIJK efflux systems contributed in a more than additive fashion to tigecycline resistance.

Citing Articles

Two classes of DNA gyrase inhibitors elicit distinct evolutionary trajectories toward resistance in gram-negative pathogens.

Leyn S, Kent J, Zlamal J, Elane M, Vercruysse M, Osterman A NPJ Antimicrob Resist. 2025; 2(1):5.

PMID: 39843513 PMC: 11702832. DOI: 10.1038/s44259-024-00021-y.


Cyclic Peptide MV6, an Aminoglycoside Efficacy Enhancer Against .

Roson-Calero N, Lucas J, Gomis-Font M, de Pedro-Jove R, Oliver A, Balleste-Delpierre C Antibiotics (Basel). 2025; 13(12).

PMID: 39766537 PMC: 11672505. DOI: 10.3390/antibiotics13121147.


Whole genome analysis revealed the role of and genes in carbapenem resistance of strains.

Mat Ghani N, Hong K, Liew Y, Lau Y, Yong H, Tee K Pathog Glob Health. 2024; 119(1-2):10-21.

PMID: 39699991 PMC: 11905307. DOI: 10.1080/20477724.2024.2442194.


AdeABC, AdeFGH, and AdeIJK efflux pumps as key factors in tigecycline resistance of Acinetobacter baumannii: a study from Western Balkan hospitals.

Novovic K, Radovanovic M, Gajic I, Vasiljevic Z, Malesevic M, Sapic K Eur J Clin Microbiol Infect Dis. 2024; 44(1):129-142.

PMID: 39538087 DOI: 10.1007/s10096-024-04974-w.


Correlation of RND efflux pump expression and AdeRS mutations in tigecycline-resistant Acinetobacter baumannii from Thai clinical isolates.

Boonsilp S, Homkaew A, Wongsuk T, Thananon K, Oonanant W Eur J Microbiol Immunol (Bp). 2024; 14(3):280-288.

PMID: 39178044 PMC: 11393643. DOI: 10.1556/1886.2024.00070.


References
1.
Magnet S, Courvalin P, Lambert T . Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454. Antimicrob Agents Chemother. 2001; 45(12):3375-80. PMC: 90840. DOI: 10.1128/AAC.45.12.3375-3380.2001. View

2.
Smith M, Gianoulis T, Pukatzki S, Mekalanos J, Ornston L, Gerstein M . New insights into Acinetobacter baumannii pathogenesis revealed by high-density pyrosequencing and transposon mutagenesis. Genes Dev. 2007; 21(5):601-14. PMC: 1820901. DOI: 10.1101/gad.1510307. View

3.
Chu Y, Chau S, Houang E . Presence of active efflux systems AdeABC, AdeDE and AdeXYZ in different Acinetobacter genomic DNA groups. J Med Microbiol. 2006; 55(Pt 4):477-478. DOI: 10.1099/jmm.0.46433-0. View

4.
Peleg A, Adams J, Paterson D . Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii. Antimicrob Agents Chemother. 2007; 51(6):2065-9. PMC: 1891386. DOI: 10.1128/AAC.01198-06. View

5.
Depardieu F, Bonora M, Reynolds P, Courvalin P . The vanG glycopeptide resistance operon from Enterococcus faecalis revisited. Mol Microbiol. 2003; 50(3):931-48. DOI: 10.1046/j.1365-2958.2003.03737.x. View